Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new release of the study record interface. This update reflects a minor backend/format change and does not modify the study data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s displayed software/content revision updated from v3.5.2 to v3.5.3, reflecting a site-level release with no apparent change to the underlying study details shown.SummaryDifference0.1%

- Check36 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3. This appears to be an administrative version update that does not affect the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe header now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices about government funding and Revision: v3.4.1 have been removed.SummaryDifference0.5%

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.